Literature DB >> 19059784

Enaminones 8: CoMFA and CoMSIA studies on some anticonvulsant enaminones.

Patrice L Jackson1, K R Scott, William M Southerland, Ya-Yin Fang.   

Abstract

3D-QSAR studies comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were carried out on 26 structurally diverse subcutaneous pentylenetetrazol (scPTZ) active enaminone analogues, previously synthesized in our laboratory. CoMFA and CoMSIA were employed to generate models to define the specific structural and electrostatic features essential for enhanced binding to the putative GABA receptor. The 3D-QSAR models demonstrated a reliable ability to predict the CLogP of the active anticonvulsant enaminones, resulting in a q(2) of 0.558 for CoMFA, and a q(2) of 0.698 for CoMSIA. The outcomes of the contour maps for both models provide detailed insight for the structural design of novel enaminone derivatives as potential anticonvulsant agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059784      PMCID: PMC3035205          DOI: 10.1016/j.bmc.2008.11.014

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  25 in total

Review 1.  Structure, function and pharmacology of voltage-gated sodium channels.

Authors:  H Denac; M Mevissen; G Scholtysik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-12       Impact factor: 3.000

2.  Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants.

Authors:  J E Foster; J M Nicholson; R Butcher; J P Stables; I O Edafiogho; A M Goodwin; M C Henson; C A Smith; K R Scott
Journal:  Bioorg Med Chem       Date:  1999-11       Impact factor: 3.641

3.  QSAR of the anticonvulsant enaminones; molecular modeling aspects and other assessments.

Authors:  T L Wilson; P L Jackson; C D Hanson; Z Xue; N D Eddington; K R Scott
Journal:  Med Chem       Date:  2005-07       Impact factor: 2.745

4.  Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.

Authors:  Jin Hee Lee; Nam Sook Kang; Sung-Eun Yoo
Journal:  Bioorg Med Chem Lett       Date:  2008-02-19       Impact factor: 2.823

5.  Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides.

Authors:  Alan J Anderson; Jesse M Nicholson; Oladapo Bakare; Ray J Butcher; Tiffany L Wilson; K R Scott
Journal:  Bioorg Med Chem       Date:  2005-10-10       Impact factor: 3.641

6.  A base-catalyzed solution-phase parallel synthesis of substituted vinylic benzamides from 3-amino-2-cyclohexanones.

Authors:  Alan J Anderson; Jesse M Nicholson; Oladapo Bakare; Ray J Butcher; K R Scott
Journal:  J Comb Chem       Date:  2004 Nov-Dec

7.  Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels.

Authors:  Samuel B Kombian; Ivan O Edafiogho; Kethireddy V V Ananthalakshmi
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

8.  Concentration-dependent effects of anticonvulsant enaminone methyl 4-(4'-bromophenyl)aminocyclohex-3-en-6-methyl-2-oxo-1-oate on neuronal excitability in vitro.

Authors:  K V V Ananthalakshmi; I O Edafiogho; S B Kombian
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

Review 9.  Enaminones: Exploring additional therapeutic activities.

Authors:  Ivan O Edafiogho; Samuel B Kombian; Kethireddy V V Ananthalakshmi; Noha N Salama; Natalie D Eddington; Tiffany L Wilson; Mariano S Alexander; Patrice L Jackson; Clive D Hanson; K R Scott
Journal:  J Pharm Sci       Date:  2007-10       Impact factor: 3.534

10.  Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet.

Authors:  Kristopher J Bough; Maryse Paquet; Jean-François Paré; Bjørnar Hassel; Yoland Smith; Randy A Hall; Raymond Dingledine
Journal:  Epilepsy Res       Date:  2007-04-09       Impact factor: 3.045

View more
  4 in total

1.  A substituted anilino enaminone acts as a novel positive allosteric modulator of GABA(A) receptors in the mouse brain.

Authors:  Ze-Jun Wang; Liqin Sun; Patrice L Jackson; Kenneth R Scott; Thomas Heinbockel
Journal:  J Pharmacol Exp Ther       Date:  2010-12-16       Impact factor: 4.030

2.  Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.

Authors:  Yong Jin Kim; Eun Ae Kim; Mi Lyang Chung; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

Review 3.  Allosteric Modulation of GABAA Receptors by an Anilino Enaminone in an Olfactory Center of the Mouse Brain.

Authors:  Thomas Heinbockel; Ze-Jun Wang; Patrice L Jackson-Ayotunde
Journal:  Pharmaceuticals (Basel)       Date:  2014-12-17

4.  6 Hz Active Anticonvulsant Fluorinated N-Benzamide Enaminones and Their Inhibitory Neuronal Activity.

Authors:  Isis J Amaye; Thomas Heinbockel; Julia Woods; Zejun Wang; Miguel Martin-Caraballo; Patrice Jackson-Ayotunde
Journal:  Int J Environ Res Public Health       Date:  2018-08-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.